Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion type Assertion NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_head.
- NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion wasGeneratedBy ECO_0000203 NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_provenance.
- NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion wasDerivedFrom befree-20140225 NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_provenance.
- NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion SIO_000772 23497415 NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_provenance.
- NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion evidence source_evidence_literature NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_provenance.
- NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_assertion description "[Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792427.RAwddagLQR7-vLV3mZsMU5ZPbaenfJn3rzdKM56hY58MY130_provenance.